Skip to main content

Clinical Trials › NCT06681623

Recruiting

A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

Sponsored by Neurology Center of New England P.C.

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
20
Target enrollment
1
U.S. states
Aug 2024
Start date
Sep 2027
Expected completion

Interventions / Treatments

Ublituximab

Conditions studied

Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis

Where this trial is running (1 site)

Foxborough

Participating MS centers on MS Buddy (1)

MS centers in Massachusetts

Compare treatment centers near a trial site by center type, providers and trials.

View Massachusetts centers
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play